Time to full publication of studies of anti-cancer medicines for breast cancer, and the potential for publication bias: a short systematic review
Takeda A, Loveman E, Harris P, Hartwell D, Welch K
Record ID 32009100015
English
Authors' recommendations:
Study found that the majority of RCTs of selected interventions for breast cancer had not reported the same outcome in both an abstract and a full publication, and that there was insufficient evidence to identify biases in terms of whether positive results were more likely to be fully published than non-significant ones.
Authors' methods:
Review
Details
Project Status:
Completed
URL for project:
http://www.hta.ac.uk/1675
Year Published:
2008
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
England, United Kingdom
MeSH Terms
- Antineoplastic Combined Chemotherapy Protocols
- Publication Bias
- Time
- Antibodies, Monoclonal
- Breast Neoplasms
- Deoxycytidine
- Paclitaxel
- Publishing
- Quinazolines
- Randomized Controlled Trials as Topic
- Taxoids
- Technology Assessment, Biomedical
Contact
Organisation Name:
NIHR Health Technology Assessment programme
Contact Address:
NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
Contact Name:
journals.library@nihr.ac.uk
Contact Email:
journals.library@nihr.ac.uk
Copyright:
2008 Queen's Printer and Controller of HMSO
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.